TSXV:CLAS.H - Post by User
Post by
cdogou812on Jul 26, 2018 3:50pm
124 Views
Post# 28373419
somthing positve:))
somthing positve:))Kalytera today announced that it will meet with the Center for Drug Evaluation and Research (CDER) of the U.S. Food and Drug Administration (FDA) on Tuesday, July 31, 2018. The meeting is to discuss numerous aspects of Kalyteras planned registration study evaluating cannabidiol (CBD) for the treatment of acute graft versus host disease (GVHD). The Company also announced it presented at 28th Annual Symposium of the International Cannabinoid Research Society. For more information read todays press release: https://kalytera.co/news/kalytera-announces-pre-ind-meeting-date-with-fda/